Vanguard Fiduciary Trust
KMTS

Vanguard Fiduciary Trust’s Kestra Medical Technologies KMTS Stock Holding History

Vanguard Fiduciary Trust’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.85M Buy
151,296
+5,599
+4% +$117K ﹤0.01% 2339
2026
Q1 		$2.9M Buy
+145,697
New +$3.43M ﹤0.01% 2370

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Vanguard Fiduciary Trust's KMTS Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Kestra Medical Technologies (KMTS) stake by 3.8% in Q2 2026, buying an estimated $117K and bringing the position to 151,296 shares worth $3.85M. The position accounts for ﹤0.01% of the portfolio, ranked #2339.

Vanguard Fiduciary Trust first reported a position in KMTS in Q1 2026 and has held it in 2 quarters since. 109 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • Vanguard Fiduciary Trust held 151,296 shares of Kestra Medical Technologies worth $3.85M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 5,599 Kestra Medical Technologies shares in Q2 2026, an estimated $117K.
  • Kestra Medical Technologies made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #2339 holding.
  • Vanguard Fiduciary Trust first reported a position in Kestra Medical Technologies in Q1 2026 and has held it in 2 quarters since.
  • 109 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.